NCT01052428
Molecular Mechanisms of Volume Overload-Aim 1(SCCOR in Cardiac Dysfunction and Disease)
See it on ClinicalTrials.gov ↗38 people
52.6%
47.4%
20 womenmiddle line = equal numbers18 men
- Phase
- PHASE2, PHASE3
- Paid for by
- University of Alabama at Birmingham
- Finished
- 2010-07
- Health conditions
- Mitral Regurgitation
- Who could join
- Anyone
- Ages
- 19 Years – 70 Years
- Average age
- mean 54.2 years
- Age 65+
- 7.9%
- Weight (BMI)
- Not reported
- Pregnancy recorded
- Not reported
- Menopause recorded
- Not reported
- Results shown by sex
- Not split by sex
- Race
- Not reported
Women left out
- No pregnant women
Women who were pregnant could not join.
“Pregnancy (negative pregnancy test and effective contraceptive methods are required prior to enrollment of females of childbearing potential).”
- Had to use birth control
Women who couldn't or didn't want to use birth control were turned away.
“Pregnancy (negative pregnancy test and effective contraceptive methods are required prior to enrollment of females of childbearing potential).”
- No kidney or liver problems
Women with kidney or liver problems were turned away.
“Renal failure with creatinine \> 2.5 mg/dl.”
- No heart disease
Women with heart disease, heart rhythm problems or a past heart attack were turned away.
“Previous myocardial infarction or percutaneous coronary intervention.”
- No cancer
Women with current or past cancer were turned away.
“Severe comorbidity: liver disease, malignancy, collagen vascular, steroid requirement.”
Study titles and rules are shown in their original English.